MSFT
Microsoft Corporation
MSFT has the edge over UCTT overall, supported by stronger valuation and lower modeled downside.
UCTT
Ultra Clean Holdings, Inc.
UCTT's outlook is improving despite an expensive valuation.
MSFT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
MSFT's revenue, profitability, cash flow and balance sheet are all currently healthy.
UCTT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Weak | |
| Stable |
UCTT's revenue and profitability are currently healthy, and its balance sheet is stable, but its cash flow is weak.
MSFT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 25x | $523 | — |
| Cheap | 27x | $525 | +0.4% |
| Current | 27x | $523 | — |
| Fair | 34x | $652 | +25% |
| Expensive | 37x | $711 | +36% |
Historical ranges are pointers, not guarantees.
MSFT has the edge over UCTT in the historical PE scenario, which offers more potential upside but is not a forecast.
UCTT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 8.4x | $48.10 | — |
| Cheap | 18x | $9.98 | -79% |
| Fair | 26x | $15.06 | -69% |
| Expensive | 47x | $26.89 | -44% |
| Current | 84x | $48.10 | — |
Historical ranges are pointers, not guarantees.
UCTT's PE is in its expensive range at 84x. If earnings grow as analysts expect, today's price would be 8.4x next year's earnings, in its cheap range.
MSFT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for MSFT, with profitability holding steady.
UCTT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
UCTT has the edge over MSFT on the outlook, with more favorable profitability expectations.
MSFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $20.79 | +8.6% |
| Q3 2026 | $19.15 | +36% |
| Q2 2026 | $17.95 | +32% |
| Q1 2026 | $16.80 | +30% |
| Q4 2025 | $15.99 | +29% |
| Q3 2025 | $14.06 | +16% |
| Q2 2025 | $13.64 | +16% |
| Q1 2025 | $12.93 | +12% |
| Q4 2024 | $12.41 | +12% |
MSFT has the edge over UCTT on earnings, with more consistent year-over-year improvement.
UCTT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.70 | +899% |
| Q3 2026 | $0.57 | +$4.14 |
| Q2 2026 | -$0.52 | +$2.86 |
| Q1 2026 | -$4.29 | -792% |
| Q4 2025 | -$4.00 | -869% |
| Q3 2025 | -$3.57 | -5200% |
| Q2 2025 | -$3.38 | -$3.18 |
| Q1 2025 | $0.62 | +$1.45 |
| Q4 2024 | $0.52 | +$1.22 |
UCTT has returned to profit: it earned $0.57 per share over the past year, after losing money the year before.
MSFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $92.3B | +19% |
| Q2 2026 | $90B | +18% |
| Q1 2026 | $82.9B | +18% |
| Q4 2025 | $81.3B | +17% |
| Q3 2025 | $77.7B | +18% |
| Q2 2025 | $76.4B | +18% |
| Q1 2025 | $70.1B | +13% |
| Q4 2024 | $69.6B | +12% |
MSFT has the edge over UCTT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 50% | +0.9 points |
| Q2 2026 | 45% | +0.2 points |
| Q1 2026 | 46% | +0.7 points |
| Q4 2025 | 47% | +1.6 points |
| Q3 2025 | 49% | +2.3 points |
| Q2 2025 | 45% | +1.8 points |
| Q1 2025 | 46% | +1.1 points |
| Q4 2024 | 45% | +1.9 points |
MSFT has the edge over UCTT on profitability, with a higher operating margin.
UCTT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $759M | +49% |
| Q2 2026 | $644.9M | +24% |
| Q1 2026 | $533.7M | +2.9% |
| Q4 2025 | $506.7M | -10% |
| Q3 2025 | $510M | -5.6% |
| Q2 2025 | $518.8M | +0.5% |
| Q1 2025 | $518.6M | +8.6% |
| Q4 2024 | $563.3M | +27% |
UCTT's revenue is growing: $759M last quarter, up 49% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.1% | +5 points |
| Q2 2026 | 4.6% | +32 points |
| Q1 2026 | 2.1% | -0.4 points |
| Q4 2025 | 2.1% | -2.4 points |
| Q3 2025 | 2.1% | -2.6 points |
| Q2 2025 | -27% | -32 points |
| Q1 2025 | 2.5% | -1.1 points |
| Q4 2024 | 4.6% | +3.6 points |
UCTT's operating margin was 7.1% last quarter, up 5 points from the same quarter a year ago.
MSFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $18.6B | -27% |
| Q2 2026 | $19.6B | -23% |
| Q1 2026 | $15.8B | -22% |
| Q4 2025 | $5.9B | -9.3% |
| Q3 2025 | $25.7B | +33% |
| Q2 2025 | $25.6B | +9.6% |
| Q1 2025 | $20.3B | -3.2% |
| Q4 2024 | $6.5B | -29% |
MSFT has the edge over UCTT on cash generation, producing positive trailing cash flow while its opponent burns cash.
UCTT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$61.8M | -$50.9M |
| Q2 2026 | -$57.3M | -562% |
| Q1 2026 | -$42.9M | -372% |
| Q4 2025 | -$2M | -$1.8M |
| Q3 2025 | -$10.9M | -$10.6M |
| Q2 2025 | $12.4M | +22% |
| Q1 2025 | $15.8M | +$24M |
| Q4 2024 | -$200K | -101% |
UCTT has burned cash in six of the last eight quarters: −$164M over the past year, against $17M the year before.
MSFT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -7M shares |
| 1 year | -0.3% | -20M shares |
| 3 years | -0.2% | -16M shares |
| 5 years | -1.6% | -121M shares |
| Available history | -3.2% | -245M shares |
MSFT has the edge over UCTT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.4B |
| Q2 2026 | $4.6B |
| Q1 2026 | $4.6B |
| Q4 2025 | $7.4B |
| Q3 2025 | $5.7B |
| Q2 2025 | $4.5B |
| Q1 2025 | $4.8B |
| Q4 2024 | $5B |
MSFT spent $21B buying back its own shares over the past year, up 5.2% from the year before.
UCTT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +100K shares |
| 1 year | +1.8% | +800K shares |
| 3 years | +4.3% | +1.9M shares |
UCTT has 46M diluted shares, up 1.8% from a year ago, despite $40M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $40M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
UCTT spent $40M buying back its own shares over the past year.
MSFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.1x | Very low |
MSFT has the edge over UCTT on leverage, with a lower net debt burden relative to earnings.
UCTT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.3x | Moderate |
| Q2 2026 | 3.1x | Elevated |
| Q1 2025 | -2.4x | Net Cash |
| Q4 2024 | 1.4x | Healthy |
| Q3 2024 | -2.8x | Net Cash |
| Q2 2024 | -3.5x | Net Cash |
| Q1 2023 | -2.6x | Net Cash |
| Q4 2022 | 1.0x | Healthy |
UCTT's net debt is about 2.3 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
MSFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.1 | Neutral |
| Stochastic | 68.0 | Neutral |
MSFT's weekly RSI is 62 (neutral) and its Stochastic is 68 (neutral).
UCTT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.1 | Oversold |
UCTT's weekly RSI is 38 (neutral) and its Stochastic is 12 (oversold).
MSFT PE vs Technology Sector
| Metric | MSFT | Sector median | Relative |
|---|---|---|---|
| PE | 27x | 28x | 2% below |
| PE % | 16 | 35 | 19 pts below |
MSFT has the edge over UCTT on valuation relative to its sector.
UCTT PE vs Technology Sector
| Metric | UCTT | Sector median | Relative |
|---|---|---|---|
| PE | 84x | 28x | 203% above |
| PE % | 90 | 35 | 55 pts above |
UCTT is trading at 84x earnings, a 203% premium to the Technology sector's median of 28x.
MSFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $524.7 | 0.3% below |
| 20 week MA | $484.8 | 7.9% above |
| 50 week MA | $446.9 | 17% above |
| 100 week MA | $453.8 | 15% above |
| 200 week MA | $411.5 | 27% above |
MSFT has the edge over UCTT on trend strength, trading above more of its moving averages.
UCTT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $56.8 | 15% below |
| 20 week MA | $73.5 | 35% below |
| 50 week MA | $67.3 | 28% below |
| 100 week MA | $46.8 | 2.9% above |
| 200 week MA | $41.6 | 16% above |
UCTT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 16% above its 200-week average.
MSFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $159.0 | $222.8 | +40% |
| 2021 | $222.8 | $334.7 | +50% |
| 2022 | $334.7 | $238.7 | -29% |
| 2023 | $238.7 | $376.0 | +58% |
| 2024 | $376.0 | $430.5 | +14% |
| 2025 | $430.5 | $487.7 | +13% |
| 2026 YTD | $487.7 | $523.0 | +7.2% |
MSFT has finished higher in five of the last six years, two of them by more than 50%. It's up 7.2% so far in 2026.
UCTT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23.4 | $31.7 | +35% |
| 2021 | $31.7 | $56.2 | +78% |
| 2022 | $56.2 | $33.3 | -41% |
| 2023 | $33.3 | $34.1 | +2.5% |
| 2024 | $34.1 | $36.5 | +7% |
| 2025 | $36.5 | $26.0 | -29% |
| 2026 YTD | $26.0 | $48.1 | +85% |
UCTT has the edge over MSFT on returns for 2026, with the stronger performance.